Big Move For Aurinia Pharmaceuticals Inc.
Tue, May 10, 2022 at 05:30 PM
Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ) soared at $11.27, representing a gain of 26%. On Mon, May 09, 2022, AUPH:NASDAQ hit a New 2-Week Low of $8.95. The stock got featured on our News Catalysts scanner on Tue, May 10, 2022 at 06:32 AM in the 'EARNINGS' category. From Mon, Apr 25, 2022, the stock recorded 30.00% Up Days and 36.36% Green Days
About Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ)
Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The Company is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.
Top 10 Gainers:
- Biohaven Pharmaceutical Holding Company Ltd. (BHVN:NYSE), 68.39%
- China XD Plastics Company Limited (CXDC:NASDAQ), 65.79%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 42.28%
- Appian Corporation (APPN:NASDAQ), 38.59%
- Vroom Inc. (VRM:NASDAQ), 32.41%
- MICT, Inc. (MICT:NASDAQ), 32.36%
- Amesite Inc. (AMST:NASDAQ), 28.49%
- Park-Ohio Holdings Corp. (PKOH:NASDAQ), 27.18%
- CECO Environmental Corp. (CECE:NASDAQ), 26.12%
- Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ), 25.99%